The New England Journal of Medicine (NEJM) Publishes Roxadustat China Phase 3 Results for the Treatment of Anemia in Chronic Kidney Disease Patients Receiving Dialysis July 24, 2019 - NASDAQ Companies 0 » View More News for July 24, 2019